首页 > 市场调查报告书 > 製药

生物标记

市场调查报告书

商品编码

1900247

生物标记技术市场规模、份额和成长分析（按测试类型、产品、分析技术、研究领域、应用和地区划分）—产业预测（2026-2033 年）

Biomarker Technologies Market Size, Share, and Growth Analysis, By Test Type (Solid Biopsy, Liquid Biopsy), By Product, By Profiling Technology, By Research Area, By Application, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球生物标记技术市场预计到 2024 年将达到 375.6 亿美元，到 2025 年将达到 410.2 亿美元，到 2033 年将达到 829.3 亿美元，预测期（2026-2033 年）的复合年增长率为 9.2%。

全球生物标记技术市场透过利用生物标记评估正常和异常的生理过程及治疗反应，在推动医疗保健发展方面发挥着至关重要的作用。这些生物标记透过聚合酵素链锁反应(PCR)、次世代定序和免疫检测等先进技术进行识别，从而揭示相关的生物学变化，并在癌症、感染疾病和自体免疫疾病等疾病的诊断中发挥关键作用。此外，生物标记还有助于在药物研发阶段早期检测药物毒性，从而支持个人化医疗的发展。疾病盛行率的上升、研发活动的增加以及早期毒性检测的日益普及是推动市场成长的主要因素。然而，高昂的初始投资和较低的认知度等挑战可能会阻碍市场发展。儘管如此，新兴经济体为未来的市场扩张提供了巨大的机会。

全球生物标誌物技术市场驱动因素

全球生物标记技术市场的主要驱动因素之一是癌症、糖尿病和心血管疾病等慢性病盛行率的不断上升。随着这些疾病的持续增长，人们对能够及早识别疾病早期阶段的早期精准诊断工具的需求日益增长。生物标记在精准医疗中发挥关键作用，能够实现个人化治疗方案，从而提高治疗效果并改善患者预后。此外，基因组学和蛋白质组学等技术的进步正在促进新生物标记的发现和检验，从而刺激这一快速发展领域的创新和投资。

限制全球生物标记技术市场的因素

全球生物标记技术市场的主要限制因素之一是先进生物标记技术研发和实施的高成本。生物标记发现和检验的复杂性以及所需的精密设备，都会给研究机构和医疗组织带来沉重的经济负担。此外，监管机构设置的监管壁垒可能会进一步延缓创新生物标记解决方案的商业化进程，并抑制该领域的投资和探索。这些因素可能导致相关人员采取谨慎态度，从而阻碍市场成长和生物标誌物技术的广泛应用。

全球生物标誌物技术市场趋势

由于个人化医疗加速融入医疗实践，全球生物标记技术市场正经历变革性的转变。随着基因组学、蛋白质组学和分子诊断技术的进步，生物标记对于优化个别患者的疾病管理以及改进诊断、预后和治疗策略至关重要。此外，对非侵入性和微创检测方法（例如液态生物检体）的需求显着增长，这些方法在提高诊断准确性的同时，也减轻了患者的负担。技术创新与以患者为中心的理念的融合，进一步加速了市场成长，并拓展了生物标记技术的应用范围。

Thermo Fisher Scientific Inc.（United States）
Bio-Rad Laboratories, Inc.（United States）
Danaher Corporation（United States）
Waters Corporation（United States）
Shimadzu Corporation（Japan）
Siemens Healthineers AG（Germany）
Illumina, Inc.（United States）
PerkinElmer, Inc.（United States）
Abbott Laboratories（United States）
Roche Holding AG（Switzerland）
Merck KGaA（Germany）
Becton, Dickinson and Company（United States）
GE Healthcare（United States）
Bruker Corporation（United States）
Hologic, Inc.（United States）
Myriad Genetics, Inc.（United States）
Bio-Techne Corporation（United States）

结论与建议

简介目录

Product Code: SQMIG35H2220

Global Biomarker Technologies Market size was valued at USD 37.56 Billion in 2024 and is poised to grow from USD 41.02 Billion in 2025 to USD 82.93 Billion by 2033, growing at a CAGR of 9.2% during the forecast period (2026-2033).

The global biomarker technologies market is vital for advancing healthcare by leveraging biological markers to evaluate normal and abnormal physiological processes and therapeutic responses. These biomarkers are identified using advanced techniques like polymerase chain reaction, next-generation sequencing, and immunoassays, playing a pivotal role in diagnosing conditions such as cancer, infectious diseases, and autoimmune disorders by highlighting relevant biological changes. Additionally, biomarkers facilitate early drug toxicity detection during development, supporting personalized medicine initiatives. Market growth is driven by rising disease prevalence, intensified research and development efforts, and increased use of early toxicity testing. However, challenges such as high initial investments and limited awareness may impede progress. Still, emerging economies present substantial opportunities for market expansion moving forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biomarker Technologies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biomarker Technologies Market Segments Analysis

Global Biomarker Technologies Market is segmented by Test Type, Product, Profiling Technology, Research Area, Application and region. Based on Test Type, the market is segmented into Solid Biopsy and Liquid Biopsy. Based on Product, the market is segmented into Biomarker Identification, Validation & Development Research and Routine Biomarker-based tests. Based on Profiling Technology, the market is segmented into Immunoassay, PCR, Imaging Technologies, Mass Spectrometry, NGS, Chromatography, Cytogenetics and Other Profiling Technologies. Based on Research Area, the market is segmented into Genomics, Proteomics, Metabolomics and Other Research Areas. Based on Application, the market is segmented into Biomarker Identification, Validation & Development Research and Routine Biomarker-based tests. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biomarker Technologies Market

One of the key market drivers for the global biomarker technologies market is the increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular disorders. As these conditions continue to rise, there is a heightened demand for early and accurate diagnostic tools that can identify diseases at their onset. Biomarkers play a crucial role in personalized medicine, enabling tailored therapeutic approaches that enhance treatment efficacy and improve patient outcomes. Furthermore, advancements in technology, such as genomics and proteomics, are facilitating the discovery and validation of new biomarkers, thus propelling innovation and investment in this rapidly evolving sector.

Restraints in the Global Biomarker Technologies Market

One key market restraint for the Global Biomarker Technologies Market is the high cost associated with research and development, as well as the implementation of advanced biomarker technologies. The complexities involved in biomarker discovery, validation, and the required sophisticated equipment can lead to significant financial burdens for research institutions and healthcare organizations. Additionally, the regulatory hurdles imposed by governing bodies can further delay the commercialization of innovative biomarker solutions, discouraging investment and exploration in this field. These factors contribute to a cautious approach from stakeholders, potentially hindering market growth and the widespread adoption of biomarker technologies.

Market Trends of the Global Biomarker Technologies Market

The global biomarker technologies market is witnessing a transformative shift, propelled by the increasing integration of personalized medicine into healthcare practices. As the understanding of genomics, proteomics, and molecular diagnostics advances, biomarkers are pivotal in tailoring disease management to individual patients, enhancing the precision of diagnosis, prognosis, and treatment strategies. Furthermore, there is a notable rise in the demand for non-invasive and minimally invasive testing methods, such as liquid biopsies, which are enhancing patient comfort while improving diagnostic accuracy. This convergence of innovation and patient-centric approaches is further fueling market growth and expanding the application scope of biomarker technologies.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement

Global Biomarker Technologies Market Size by Test Type & CAGR (2026-2033)

Market Overview
Solid Biopsy
Liquid Biopsy

Global Biomarker Technologies Market Size by Product & CAGR (2026-2033)

Market Overview
Biomarker Identification, Validation & Development Research
- Consumables
- Instruments
- Services
- Software
Routine Biomarker-based tests
- Consumables
- Instruments
- Services
- Software

Global Biomarker Technologies Market Size by Profiling Technology & CAGR (2026-2033)

Market Overview
Immunoassay
- ELISA
- Western Blot
- Protein Microarray
PCR
Imaging Technologies
Mass Spectrometry
NGS
Chromatography
Cytogenetics
Other Profiling Technologies

Global Biomarker Technologies Market Size by Research Area & CAGR (2026-2033)

Market Overview
Genomics
Proteomics
Metabolomics
- Metabolic Flux
- Lipidomics
- Others
Other Research Areas

Global Biomarker Technologies Market Size by Application & CAGR (2026-2033)

Market Overview
Biomarker Identification, Validation & Development Research
Routine Biomarker-based tests

Global Biomarker Technologies Market Size & CAGR (2026-2033)

North America (Test Type, Product, Profiling Technology, Research Area, Application)
- US
- Canada
Europe (Test Type, Product, Profiling Technology, Research Area, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Test Type, Product, Profiling Technology, Research Area, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Test Type, Product, Profiling Technology, Research Area, Application)
- Brazil
- Rest of Latin America
Middle East & Africa (Test Type, Product, Profiling Technology, Research Area, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Waters Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments